SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Poly Medicure reports Profit after tax of Rs 371.45 Mln, in the March 2021 quarter

24 May 2021 Evaluate
The Sales for the quarter ended March 2021 of Rs. 2025.09 millions rose by 27.22% from Rs. 1591.75 millions.Net profit surges 80.21% to Rs. 371.45  millions  from Rs. 206.12 millions in the quarter ended March 2021.Operating profit for the quarter ended March 2021 rose to 603.42 millions as compared to 434.13 millions of corresponding quarter ended March 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202103 202003 % Var 202103 202003 % Var 202103 202003 % Var
Sales 2025.09 1591.75 27.22 7473.82 6461.62 15.66 7473.82 6461.62 15.66
Other Income 74.31 54.18 37.15 192.88 185.84 3.79 192.88 185.84 3.79
PBIDT 603.42 434.13 39.00 2276.10 1787.21 27.35 2276.10 1787.21 27.35
Interest -19.74 79.15 -124.94 79.12 176.55 -55.19 79.12 176.55 -55.19
PBDT 623.16 354.98 75.55 2196.98 1610.66 36.40 2196.98 1610.66 36.40
Depreciation 122.13 90.93 34.31 463.14 392.84 17.90 463.14 392.84 17.90
PBT 501.03 264.05 89.75 1733.84 1217.82 42.37 1733.84 1217.82 42.37
TAX 129.58 57.93 123.68 438.72 294.00 49.22 438.72 294.00 49.22
Deferred Tax 19.16 -13.64 -240.47 -0.83 -38.41 -97.84 -0.83 -38.41 -97.84
PAT 371.45 206.12 80.21 1295.12 923.82 40.19 1295.12 923.82 40.19
Equity 479.40 441.24 8.65 479.40 441.24 8.65 479.40 441.24 8.65
PBIDTM(%) 29.80 27.27 9.25 30.45 27.66 10.11 30.45 27.66 10.11

Poly Medicure Share Price

1454.90 -13.35 (-0.91%)
20-Apr-2026 15:29 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 536.15
Poly Medicure 1454.90
Laxmi Denta 192.50
Nureca Ltd. 259.30
Hemant Surgical Inds 308.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×